Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 20:11:1549-1555.
doi: 10.2147/IDR.S170952. eCollection 2018.

Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada

Eta E Ashu  1 , Gregory A Korfanty  1 , Himeshi Samarasinghe  1 , Nicole Pum  1 , Man You  1 , Deborah Yamamura  2 , Jianping Xu  1
Affiliations

Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada

Eta E Ashu et al. Infect Drug Resist. .

Abstract

Purpose: Amphotericin B (AMB) is one of the major antifungal drugs used in the management of aspergillosis and is especially recommended for treating triazole-resistant strains of Aspergillus fumigatus. However, relatively little is known about the AMB susceptibility patterns of A. fumigatus in many parts of the world. This study aims to describe the AMB susceptibility patterns in Hamilton, Ontario, Canada.

Methods: The in vitro susceptibilities of 195 environmental and clinical A. fumigatus isolates to AMB were tested by the broth microdilution method as per the Clinical and Laboratory Standards Institute's guidelines. Catalase-generated oxygen bubbles trapped by Triton X-100 were used to quantify catalase activity in a representative group of isolates.

Results: Of the 195 isolates, 188 (96.4%) had the minimum inhibitory concentration (MIC) of AMB ≥2 mg/L, with approximately 80% and 20% of all clinical and environmental isolates having MICs of ≥ 4 mg/L. Overall, the clinical isolates were less susceptible to AMB than environmental isolates (P-value <0.001). The strain with the highest AMB MIC (16 mg/L) had one of the highest catalase activities. However, there was no correlation between AMB MIC and catalase activity in our sample.

Conclusion: The widespread AMB resistance suggests that using AMB in the management of A. fumigatus infections in Hamilton would likely result in treatment failure. Although high catalase activity may have contributed to AMB resistance in some isolates, the mechanism(s) for the observed AMB resistance in Hamilton is unknown and likely complex.

Keywords: Aspergillus fumigatus; Canada; Hamilton; amphotericin B; catalase activity; resistance.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev. 2009;22(3):447–465. - PMC - PubMed
    1. Maturu VN, Agarwal R. Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose? Lung India. 2015;32(4):309–312. - PMC - PubMed
    1. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009;135(3):805–826. - PubMed
    1. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173(7):707–717. - PubMed
    1. Patterson TF, Thompson GR, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60. - PMC - PubMed